Multi-modal analysis of human hepatic stellate cells identifies novel therapeutic targets for metabolic dysfunction-associated steatotic liver disease

Herein, we present the results of a multi-modal sequencing analysis of human hepatic stellate cells (HSCs) from NORMAL, MASL (metabolic dysfunction-associated steatotic liver), and metabolic dysfunction-associated steatohepatitis (MASH) livers. We identified additional subclusters that were not detected by previous studies and characterized the mechanism by which HSCs are activated in MASH livers, including the transcriptional machinery that induces the transdifferentiation of HSCs into myofibroblasts. For the first time, we described the pathogenic role of activated HSC-derived PAI-1 (a product of the SERPINE1 gene) in the development of MASH liver fibrosis. Targeting the RUNX1/2-SERPINE1 axis could be a novel strategy for the treatment of liver fibrosis in patients.

Authors

Institutions

Publication Details

Journal
Journal of Hepatology
Published
2024-11-08
DOI
https://doi.org/10.1016/j.jhep.2024.10.044
Citations
43
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
16.62

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multi-modal analysis of human hepatic stellate cells identifies novel therapeutic targets for metabolic dysfunction-associated steatotic liver disease

Justin Buchanan, Huayi Zhao, Sebastian Preißl, David A. Brenner et al.
43 citations
Journal of Hepatology
Liver Disease Diagnosis and Treatment
16.62
article

Multi-modal analysis of human hepatic stellate cells identifies novel therapeutic targets for metabolic dysfunction-associated steatotic liver disease

Justin Buchanan, Huayi Zhao, Sebastian Preißl, David A. Brenner, Tatiana Kisseleva, Cuijuan Han, Daisy Chilin-Fuentes, Charlene Miciano, Allen Wang, Michael Miller, Olivier Poirion, Sara Brin Rosenthal, Xiaomeng Hou, Bing Ren, Karin Diggle, Sadatsugu Sakane, Hyun Young Kim, Xiao Liu, Raquel Carvalho‐Gontijo Weber, Wonseok Lee, Christopher K. Glass, Mojgan Housseini
article en
43 citations

Abstract

Herein, we present the results of a multi-modal sequencing analysis of human hepatic stellate cells (HSCs) from NORMAL, MASL (metabolic dysfunction-associated steatotic liver), and metabolic dysfunction-associated steatohepatitis (MASH) livers. We identified additional subclusters that were not detected by previous studies and characterized the mechanism by which HSCs are activated in MASH livers, including the transcriptional machinery that induces the transdifferentiation of HSCs into myofibroblasts. For the first time, we described the pathogenic role of activated HSC-derived PAI-1 (a product of the SERPINE1 gene) in the development of MASH liver fibrosis. Targeting the RUNX1/2-SERPINE1 axis could be a novel strategy for the treatment of liver fibrosis in patients.

Journal of HepatologyVol. 82(5)
University of Freiburg (DE), Sanford Burnham Prebys Medical Discovery Institute (US), Discovery Institute (US), UC San Diego Health System (US), University of California San Diego (US)
National Research Foundation, National Research Foundation of Korea, National Institutes of Health, University of California, San Diego, School of Medicine, University of California, San Diego
Good health and well-being
Openalex Percentile: Top 1%
Liver Disease Diagnosis and Treatment
16.62
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.